Vanda Pharmaceuticals (VNDA) Return on Equity [ROE] (2009 - 2026)
Vanda Pharmaceuticals' Return on Equity [ROE] came in at -109.75% for Q2 2026, down 96.34 percentage points from -13.41% a year earlier and down 30.94 percentage points from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Vanda Pharmaceuticals' Return on Equity [ROE] was -50.93%, down 47.44 percentage points from FY2024.
- Return on Equity [ROE] has declined in each of the last four years, with a five-year change of -56.33 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -3.49% in FY2024 (-3.96 pp), 0.47% in FY2023 (-0.75 pp), 1.22% in FY2022 (-5.70 pp) and 6.92% in FY2021 (+1.52 pp).
- The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] since Q3 2014.
- Year-over-year, Return on Equity [ROE] has declined for 11 consecutive quarters, with an average year-over-year change of -32.70 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 2.60 percentage points), and the weakest in Q2 2026 (a drop of 96.34 percentage points).
- Business Quant data shows VNDA's Return on Equity [ROE] at -78.81% (Q1 2026), -55.59% (Q4 2025) and -17.67% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn | -130.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -130.89% |
| Jun 30, 2026 | -109.75% |
| Mar 31, 2026 | -78.81% |
| Dec 31, 2025 | -55.59% |
| Sep 30, 2025 | -17.67% |
| Jun 30, 2025 | -13.41% |
| Mar 31, 2025 | -8.42% |
| Dec 31, 2024 | -3.50% |
| Sep 30, 2024 | -3.02% |
| Jun 30, 2024 | -2.00% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | 0.46% |
| Sep 30, 2023 | 2.18% |
| Jun 30, 2023 | 2.76% |
| Mar 31, 2023 | 3.00% |
| Dec 31, 2022 | 1.21% |
| Sep 30, 2022 | 1.27% |
| Jun 30, 2022 | 2.17% |
| Mar 31, 2022 | 3.57% |
| Dec 31, 2021 | 6.62% |
API Access
Vanda Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();